Lorcaserin Extended-Release Tablets and MenHibrix
Determining the interaction of Lorcaserin Extended-Release Tablets and MenHibrix and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
Brand name: MenHibrix
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Meni-D
- Lorcaserin Extended-Release Tablets-Meningococcal (Groups A / C / Y and W-135) Diphtheria Conjugate Vaccine
- Lorcaserin Extended-Release Tablets-Meningococcal conjugate vaccine
- Lorcaserin Extended-Release Tablets-Meningococcal group B vaccine
- Lorcaserin Extended-Release Tablets-Meningococcal Groups A, C, Y, and W-135 Vaccine
- Lorcaserin Extended-Release Tablets-Meningococcal Poly (Groups C & Y) & b Conj Vaccine
- MenHibrix-Lorcaserin Hydrochloride
- MenHibrix-Lorcaserin Tablets
- MenHibrix-Lorcet
- MenHibrix-Lorcet Plus
- MenHibrix-Lorcet Tablets
- MenHibrix-Lorlatinib